Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
52.8M
-
Shares change
-
-2.16M
-
Total reported value, excl. options
-
$583M
-
Value change
-
-$17.1M
-
Put/Call ratio
-
0.48
-
Number of buys
-
63
-
Number of sells
-
-47
-
Price
-
$11.05
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q4 2021
136 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q4 2021.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.8M shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (13.7M shares), Madison Avenue Partners, LP (6.65M shares), VANGUARD GROUP INC (6.3M shares), ORBIMED ADVISORS LLC (5.97M shares), Weiss Asset Management LP (2.6M shares), FMR LLC (2.59M shares), STATE STREET CORP (1.36M shares), Chescapmanager LLC (1.26M shares), GEODE CAPITAL MANAGEMENT, LLC (1.04M shares), and JACOBS LEVY EQUITY MANAGEMENT, INC (1.02M shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.